Open Access
Issue
Published:
30 November 2022
Formulation and Evaluation of Letrozole Nanoparticles by Salting Out Technique and Determination of Anti-cancer Activity by MTT Assay
Download citation
875
Views
121
Downloads
1
Crossref
N/A
WoS
0
Scopus
N/A
CSCD
Letrozole (LTZ) drug is an aromatase inhibitor used for the treatment of hormonally positive breast cancer in postmenopausal women. It has poor water solubility, rapid metabolism and a range of side effects. In this study, polymer-based nanoparticles (NPs) incorporating the drug have been formulated and evaluated, aimed to control the release, potentially maximize the therapeutic efficiency, and minimize the side effects of the drug.
The drug is incorporated into the polymer (i.e., Eudragit S 100 and Ethyl cellulose) by employing the salting out technique. Total twelve formulations were prepared by varying drug-polymer concentrations and organic to aqueous phase ratios and evaluated for percentage yield, drug content and invitro drug release studies. Out of 12 formulations, the best formulations were selected based on drug content and invitro drug release studies and characterized for mean particle diameter and zeta potential.
Among all the twelve formulations F5EC, 1:2 was considered to be the best formulation with minimum particle size of 194.55 nm, zeta potential value of –18.6 mV, drug content of 90.28%, entrapment efficiency of 92.36%, and invitro drug release of 95% within 12 h. The drug release kinetic studies of the best formulations indicated that the release of drug followed zero order kinetics and showed non-fickian diffusion mechanism. Based on the evaluation and characterization of the formulations, the best formulation prepared by salting out technique (F5EC 1:2) was considered for the determination of anti-cancer activity invitro in MCF-7 breast cancer cell line by MTT assay. The results indicated that the prepared formulation exhibited anti-cancer activity with an IC50 value of 49.63 ng.
Finally, by comparing results, Ethyl cellulose (EC) was considered to be most suitable for the preparation of LTZ NPs by salting out technique. The Entrapment Efficiency of LTZ NPs was improved up to 92.36% by using salting out technique.
menu
Formulation and Evaluation of Letrozole Nanoparticles by Salting Out Technique and Determination of Anti-cancer Activity by MTT Assay
Abstract
Letrozole (LTZ) drug is an aromatase inhibitor used for the treatment of hormonally positive breast cancer in postmenopausal women. It has poor water solubility, rapid metabolism and a range of side effects. In this study, polymer-based nanoparticles (NPs) incorporating the drug have been formulated and evaluated, aimed to control the release, potentially maximize the therapeutic efficiency, and minimize the side effects of the drug.
The drug is incorporated into the polymer (i.e., Eudragit S 100 and Ethyl cellulose) by employing the salting out technique. Total twelve formulations were prepared by varying drug-polymer concentrations and organic to aqueous phase ratios and evaluated for percentage yield, drug content and invitro drug release studies. Out of 12 formulations, the best formulations were selected based on drug content and invitro drug release studies and characterized for mean particle diameter and zeta potential.
Among all the twelve formulations F5EC, 1:2 was considered to be the best formulation with minimum particle size of 194.55 nm, zeta potential value of –18.6 mV, drug content of 90.28%, entrapment efficiency of 92.36%, and invitro drug release of 95% within 12 h. The drug release kinetic studies of the best formulations indicated that the release of drug followed zero order kinetics and showed non-fickian diffusion mechanism. Based on the evaluation and characterization of the formulations, the best formulation prepared by salting out technique (F5EC 1:2) was considered for the determination of anti-cancer activity invitro in MCF-7 breast cancer cell line by MTT assay. The results indicated that the prepared formulation exhibited anti-cancer activity with an IC50 value of 49.63 ng.
Finally, by comparing results, Ethyl cellulose (EC) was considered to be most suitable for the preparation of LTZ NPs by salting out technique. The Entrapment Efficiency of LTZ NPs was improved up to 92.36% by using salting out technique.
References(35)
H. Sung, J. Ferlay, R.L. Siegel, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 2021, 71(3): 209–249. https://doi.org/10.3322/caac.21660
C.E. DeSantis, S.A. Fedewa, A. Goding Sauer, et al. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA: A Cancer Journal for Clinicians, 2016, 66(1): 31–42. https://doi.org/10.3322/caac.21320
O. Ginsburg, F. Bray, M.P. Coleman, et al. The global burden of women's cancers: A grand challenge in global health. Lancet, 2017, 389(10071): 847–860. https://doi.org/10.1016/s0140-6736(16)31392-7
P. Porter. "Westernizing" women's risks? Breast cancer in lower-income countries. The New England Journal of Medicine, 2008, 358: 213–216. https://doi.org/10.1056/nejmp0708307
N.K. Jain. Controlled and novel drug delivery. New Delhi, India: CBS Publication, 1997: 130–147.
S.K. Dey, B. Mandal, M. Bhowmik, et al. Development and in vitro evaluation of Letrozole loaded biodegradable nanoparticles for breast cancer therapy. Brazilian Journal of Pharmaceutical Sciences, 2009, 45(3): 585–591. https://doi.org/10.1590/s1984-82502009000300025
P. Couvreur. Nanoparticles in drug delivery: Past, present and future. Advanced Drug Delivery Reviews, 2013, 65(1): 21–23. http://dx.doi.org/10.1016/j.addr.2012.04.010
K.S. Soppimath, T.M. Aminabhavi, A.R. Kulkarni, et al. Biodegradable polymeric nanoparticles as drug delivery devices. Journal of Controlled Release, 2001, 70(1–2): 1–20. http://dx.doi.org/10.1016/S0168-3659(00)00339-4
S. Parveen, S.K. Sahoo. Polymeric nanoparticles for cancer therapy. Journal of Drug Targeting, 2008, 16(2): 108–123. https://doi.org/10.1080/10611860701794353
M. Zohri, T. Gazori, S. Mirdamadi, et al. Polymeric nanoparticles: Production, applications and advantage [J]. The Internet Journal of Nanotechnology, 2009, 3(1): 1–14.
S. Gelperina, K. Kisich, M.D. Iseman, et al. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. American Journal of Respiratory and Critical Care Medicine, 2005, 172(12): 1487–1490. https://doi.org/10.1164/rccm.200504-613pp
A.K. Sailaja, P. Amareshwar, P. Chakravarty. Different techniques used for the preparation of nanoparticles using natural polymers and their application. International Journal of Pharmacy and Pharmaceutical Sciences, 2011, 3(S2): 45–50.
B.V.N. Nagavarma, H.K. Yadav, A.V.L.S. Ayaz, et al. Different techniques for preparation of polymeric nanoparticles – a review. Asian Journal of Pharmaceutical and Clinical Research, 2012, 5(S3): 16–23.
R. Tiruwa. A review on nanoparticles: Preparation and evaluation parameters. Indian Journal of Pharmaceutical and Biological Research, 2016, 4(2): 27–31. https://doi.org/10.30750/ijpbr.4.2.4
C.I.C. Crucho, M.T. Barros. Polymeric nanoparticles: A study on the preparation variables and characterization methods. Materials Science and Engineering: C, 2017, 80: 771–784. https://doi.org/10.1016/j.msec.2017.06.004
D.R. Baer, D.J. Gaspar, P. Nachimuthu, et al. Application of surface chemical analysis tools for characterization of nanoparticles. Analytical and Bioanalytical Chemistry, 2010, 396: 983–1002. http://dx.doi.org/10.1007/s00216-009-3360-1
R. Tiruwa. A review on nanoparticles – preparation and evaluation parameters. Indian Journal of Pharmaceutical and Biological Research, 2016, 4(2): 27–31. https://doi.org/10.30750/ijpbr.4.2.4
M. De, P.S. Ghosh, V.M. Rotello. Applications in nanoparticles in biology. Advanced Matrrials, 2008, 20: 4225–4241. https://dx.doi.org/10.1002/adma.200703183
O.V. Salata. Applications of nanoparticles in biology and medicine. Journal of Nanobiotechnology, 2004, 2: 3. https://doi.org/10.1186/1477-3155-2-3
H.S. Choi, W.H. Liu, F.B. Liu, et al. Design considerations for tumour-targeted nanoparticles. Nature Nanotechnology, 2010, 5: 42–47. https://doi.org/10.1038/nnano.2009.314
S. Hirsjärvi, C. Passirani, J.P. Benoit. Passive and active tumour targeting with nanocarriers. Current Drug Discovery Technologies, 2011, 8(3): 188–196. https://doi.org/10.2174/157016311796798991
Y. Yun, Y.W. Cho, K. Park. Nanoparticles for oral delivery: Targeted nanoparticles with peptidic ligands for oral protein delivery. Advanced Drug Delivery Reviews, 2013, 65(6): 822–832. http://dx.doi.org/10.1016/j.addr.2012.10.007
H.Y. Tian, J. Chen, X.S. Chen. Nanoparticles for gene delivery. Small, 2013, 9(12): 2034–2044. https://doi.org/10.1002/smll.201202485
C. Saraiva, C. Praça, R. Ferreira, et al. Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. Journal of Controlled Release, 2016, 235: 34–47. http://dx.doi.org/10.1016/j.jconrel.2016.05.044
M. Ma, Y.M. Shu, Y.H. Tang, et al. Multifaceted application of nanoparticle-based labeling strategies for stem cell therapy. Nano Today, 2020, 34: 100897. http://dx.doi.org/10.1016/j.nantod.2020.100897
X. Bai, Y.Y. Wang, Z.Y. Song, et al. The basic properties of gold nanoparticles and their applications in tumor diagnosis and treatment. International Journal of Molecular Sciences, 2020, 21(7): 2480. https://doi.org/10.3390/ijms21072480
A.K. Sailaja, C. Vineela. Preparation of mefenamic acid loaded ethyl cellulose and eudragit® S100 nanoparticles by nanoprecipitation technique and a comparative study between two polymers for the formulation of mefenamic acid nanoparticles. Current Nanomedicine, 2018, 8(2): 100–108. https://doi.org/10.2174/2468187308666180124155526
S.J. Cao, S. Xu, H.M. Wang, et al. Nanoparticles: Oral delivery for protein and peptide drugs. AAPS Pharm Sci Tech, 2019, 20(5): 190. doi:10.1208/s12249-019-1325-z
Publication history
Copyright
Rights and permissions
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
FEEDBACK 
TOP